Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2022 Jan 1;89(1):98–107. doi: 10.1097/QAI.0000000000002827

Figure 2. Prevalence of latent tuberculosis infection by TST and QFT-Plus among pregnant women by HIV status.

Figure 2.

Abbreviations: LTBI, latent tuberculosis infection; QFT-Plus, QuantiFERON-TB Gold Plus; TST, tuberculin skin test

TST positive defined as ≥5 mm induration for women living with HIV (HIV+) and ≥10mm induration if HIV negative (HIV−)

*** indicates p<0.0001, ** indicates p<0.005